Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BAXTER HLTHCARE

  • FDA Approval
  • March 27, 2024, 09:17 UTC
  • 33
  • 0 comments

FDA approve CEFTRIAXONE SODIUM

Comment Full text

MERCK SHARP DOHME

  • FDA Approval
  • March 26, 2024, 21:11 UTC
  • 39
  • 0 comments

FDA approve SOTATERCEPT-CSRK

Comment Full text

MYLAN

  • FDA Approval
  • March 25, 2024, 19:11 UTC
  • 37
  • 0 comments

FDA approve EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

Comment Full text

ACTELION

  • FDA Approval
  • March 25, 2024, 19:11 UTC
  • 41
  • 0 comments

FDA approve MACITENTAN AND TADALAFIL

Comment Full text

TAKEDA PHARMS USA

  • FDA Approval
  • March 25, 2024, 17:44 UTC
  • 40
  • 0 comments

FDA approve MARIBAVIR

Comment Full text

ASTRAZENECA

  • FDA Approval
  • March 25, 2024, 17:22 UTC
  • 41
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

MYLAN

  • FDA Approval
  • March 25, 2024, 08:46 UTC
  • 36
  • 0 comments

FDA approve DEFERASIROX

Comment Full text

NOVAST LABS

  • FDA Approval
  • March 25, 2024, 08:46 UTC
  • 33
  • 0 comments

FDA approve FLUOROURACIL

Comment Full text

NOVAST LABS

  • FDA Approval
  • March 25, 2024, 08:46 UTC
  • 32
  • 0 comments

FDA approve FLUOROURACIL

Comment Full text

YUNG SHIN PHARM

  • FDA Approval
  • March 25, 2024, 08:46 UTC
  • 32
  • 0 comments

FDA approve DICLOFENAC SODIUM; MISOPROSTOL

Comment Full text
  • Previous
  • 492
  • 493
  • 494
  • 495
  • 496
  • Next

Search

News categories

  • Technical Exchange News(11746)
  • Event(4190)
  • SEC News(233972)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(142999)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin